Back to search

Article

Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation

2018-08-01

Abstract excerpt

Unphysiological reactive oxygen species (ROS) formation is considered an important pathomechanism for several disease phenotypes with high unmet medical need. Therapeutically, antioxidants have failed multiple times. Instead, focusing on only disease-relevant, enzymatic sources of ROS appears to be a more promising and highly validated approach. Here the family of five NADPH oxidases (NOX) stands out as drug targe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eec50ed8-b7b5-56ae-97bf-9b30cbb5a0a5
DOI
10.1101/382226
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validationDOI 10.1101/382226
Select a neighboring publication to make it the new centre.